Avidity Partners Management LP Coherus Bio Sciences, Inc. Transaction History

Avidity Partners Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $17.8 Million - $20.4 Million	-1,023,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $9.26 Million - $12.3 Million	641,500 Added 167.93%	1,023,500 $18.3 Million
Q1 2020 Jun 17, 2020	BUY	$11.67 - $22.53 $4.46 Million - $8.61 Million	382,000 New	382,000 $6.2 Million
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $2.5 Million - $4.83 Million	-214,500 Closed	0 $0
Q4 2019 Jun 17, 2020	BUY	$16.33 - $21.37 $3.5 Million - $4.58 Million	214,500 New	214,500 $3.86 Million

143

82.7M

79.1K

100K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $80.8M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.